Steady-state pharmacokinetics of OROS® methylphenidate in adolescents with ADHD

被引：0
|
作者：
Auiler, JF [1 ]
Parasrampuria, DA [1 ]
Gelotte, CK [1 ]
Zinsenheim, JR [1 ]
Silber, SS [1 ]
Bowen, DL [1 ]
机构：
[1] McNeil Consumer & Specialty Pharmaceut, Ft Washington, PA USA
来源：
PEDIATRIC RESEARCH | 2004年 / 55卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R72 [儿科学];
学科分类号：
100202 ;
摘要：
3341
引用
收藏
页码：589A / 589A
页数：1
相关论文
共 50 条
  • [1] Effects of OROS methylphenidate (OROS MPH) treatment in children and adolescents with ADHD, mental retardation and epilepsy
    Kesic, A.
    Lakic, A.
    Dronjak, D.
    Stupar, D.
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2012, 22 : S420 - S421
  • [2] Assessment of cognitive domains during treatment with OROS methylphenidate in adolescents with ADHD
    Hammerness, Paul
    Fried, Ronna
    Petty, Carter
    Meller, Benjamin
    Biederman, Joseph
    [J]. CHILD NEUROPSYCHOLOGY, 2014, 20 (03) : 319 - 327
  • [3] Transitioning to OROS® methylphenidate from atomoxetine is effective in children and adolescents with ADHD
    Niederkirchner, Kaethe
    Slawik, Lara
    Wermelskirchen, Detlef
    Rettig, Klaus
    Schaeuble, Barbara
    [J]. EXPERT REVIEW OF NEUROTHERAPEUTICS, 2011, 11 (04) : 499 - 508
  • [4] Treatment of adolescent ADHD with OROS® methylphenidate
    McBurnett, K
    [J]. PEDIATRIC RESEARCH, 2003, 53 (04) : 555A - 555A
  • [5] The effects of transdermal methylphenidate with reference to OROS methylphenidate in ADHD
    Lopez, Frank A.
    Shingler, Tarra
    Heinlein, Kristen
    [J]. JOURNAL OF DEVELOPMENTAL AND BEHAVIORAL PEDIATRICS, 2006, 27 (05): : 441 - 442
  • [6] Impact of OROS® methylphenidate on real-life driving performance of adolescents with ADHD
    Cox, DJ
    Humphrey, JW
    Merkel, RL
    Penberthy, JK
    Kovatchev, B
    [J]. PEDIATRIC RESEARCH, 2004, 55 (04) : 2A - 2A
  • [7] Steady-state pharmacokinetics and tolerability of modafinil given alone or in combination with methylphenidate in healthy volunteers
    Hellriegel, ET
    Arora, S
    Nelson, M
    Robertson, P
    [J]. JOURNAL OF CLINICAL PHARMACOLOGY, 2001, 41 (08): : 895 - 904
  • [8] STEADY-STATE PHARMACOKINETICS OF PENTANE
    ALLERHEILIGEN, SB
    LUDDEN, TM
    BURK, RF
    LANE, JM
    [J]. FEDERATION PROCEEDINGS, 1985, 44 (04) : 1116 - 1116
  • [9] STEADY-STATE PHARMACOKINETICS OF TESTOLACTONE
    PASCUCCI, VL
    YEAGER, RL
    SHERINS, RJ
    CLARK, RV
    CHATTERJI, DC
    [J]. DRUG INTELLIGENCE & CLINICAL PHARMACY, 1983, 17 (06): : 447 - 447
  • [10] OROS® formulation of methylphenidate in treatment for ADHD:: Duration of effect
    Wigal, SB
    [J]. PEDIATRIC RESEARCH, 2002, 51 (04) : 21A - 21A
12345